Levodopa: alterations in behavior

Clin Pharmacol Ther. Mar-Apr 1971;12(2):383-96. doi: 10.1002/cpt1971122part2383.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adjustment Disorders / drug therapy*
  • Aged
  • Anger / drug effects
  • Bipolar Disorder / drug therapy*
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Female
  • Glycols / urine
  • Humans
  • Hydrazines / therapeutic use
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Male
  • Parkinson Disease / drug therapy*
  • Phenylacetates / cerebrospinal fluid
  • Placebos
  • Time Factors
  • Vanilmandelic Acid / urine

Substances

  • Glycols
  • Hydrazines
  • Phenylacetates
  • Placebos
  • Hydroxyindoleacetic Acid
  • Vanilmandelic Acid
  • Dihydroxyphenylalanine